AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

HHS and the Justice Department have launched a six-month pilot allowing healthcare companies to voluntarily disclose and resolve certain civil False Claims Act violations. Home-based care experts say it offers more defined terms for addressing billing problems, but repayment costs, potential exposure and the program’s limits remain concerns.

The U.S. Department of Health and Human Services and the Justice Department’s Civil Division have launched a six-month self-disclosure pilot that lets healthcare companies, including home-based care providers, voluntarily report certain civil False Claims Act violations and seek a coordinated resolution. The initiative offers a defined route for addressing billing problems, but industry representatives say repayment costs and the risks facing smaller providers remain unresolved.

The Healthcare False Claims Act Self-Disclosure Pilot Program applies to healthcare companies that voluntarily disclose civil conduct potentially violating the federal False Claims Act. According to the DOJ, the law can impose liability of three times the government’s damages, plus an inflation-linked penalty, when an entity knowingly submits or causes false claims to be submitted to the government. The pilot provides for a coordinated civil release of liability under the False Claims Act and certain HHS administrative authorities.

Before you orderOffer from Amazon

Get oils, diffusers and self-care delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Monica Cutia, vice president of clinical operations at HealthView Home Health & Hospice, told Home Health Care News that providers may find the program useful when internal audits reveal patterns of documentation problems with billing consequences. She cited examples such as a late certification or a face-to-face note that does not meet all CMS billing requirements. Cutia said these issues are not typically fraud at her company, but providers previously lacked a clear account of what would happen if they reported a pattern.

Cutia said the pilot sets a more defined process for reporting, repayment and resolution, and could be relevant to regional providers with the capacity to conduct audits, as well as organizations acquiring agencies that want to address known inherited liabilities. The Home Care Association of America (HCAOA), which represents more than 5,000 home care agencies, said it supports the initiative and wants HHS and DOJ to consider extending it or making it permanent if appropriate.

At a glance
announcementWhen: Announced Thursday; the six-month pilot…
The developmentHHS and the DOJ Civil Division announced a six-month program for healthcare companies to disclose and resolve certain civil False Claims Act violations.

A Clearer Route for Billing Corrections

For providers that find possible billing violations through internal audits, a defined disclosure process could make it easier to decide how to report and repay improper claims. Cutia told Home Health Care News that the uncertainty around what followed a disclosure had affected how operators handled patterns of documentation errors. A clearer process may also give buyers of home care agencies a way to address certain known liabilities during a transaction.

The potential stakes are financial and operational. The HCAOA said organizations acting in good faith should be able to address civil liability without facing exclusion from federal programs, a Corporate Integrity Agreement or CMS enrollment revocation. But the association warned that repayment multipliers could strain small community-based providers with limited reserves. Whether the pilot makes disclosure manageable for those organizations will depend on how cases are handled and what payments are required.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

Civil Claims, Not Every Compliance Risk

The False Claims Act concerns knowingly submitting, or causing the submission of, false claims to the government. Under the new pilot, eligible companies can seek a coordinated civil resolution covering the Act and some HHS administrative authorities. A Corporate Integrity Agreement, or CIA, is a separate agreement with the HHS Office of Inspector General that sets compliance requirements as part of a civil settlement.

Cutia stressed that the pilot is limited to civil matters and runs for six months; she said it does not change the broader enforcement posture. She also warned that conduct involving referrals—such as paying for admissions, providing free staffing or supplies to a facility, or medical director contracts that do not reflect the work—may raise issues under the Anti-Kickback Statute, which she described as criminal and outside this pilot. The program should not be read as covering every potential compliance violation.

“Companies that identify and report potential violations should have a clear way to correct them, repay the government and continue serving people in federal healthcare programs.”

— Dr. Mehmet Oz, CMS administrator, in a Thursday statement

Costs and Eligibility Still Need Answers

The source report does not specify how HHS and DOJ will calculate repayment amounts in individual cases, how the pilot will apply the False Claims Act’s damages and penalty provisions, or which disclosures will qualify for a coordinated release. The practical financial burden for small providers also remains uncertain. HCAOA called for possible waivers of the repayment multiplier and suggested requiring repayment only of fraudulent transactions; the available details do not establish whether officials will adopt those suggestions.

The program’s limits also matter: it covers certain civil False Claims Act matters and some HHS administrative authorities, not every kind of misconduct. The reported material does not describe application procedures, case timelines or how the agencies will treat borderline documentation errors. Providers will need to determine whether their circumstances meet the pilot’s requirements before relying on it.

Pilot Runs Through April 2027

The pilot is scheduled to run for six months, ending April 22, 2027. HHS and DOJ will administer the disclosure and resolution process; further guidance on eligibility, repayment and case handling would help providers assess whether to participate. HCAOA has urged the agencies to consider extending the program or making it permanent, but no extension or permanent program has been announced in the source material.

In the meantime, home-based care operators can review audit findings with compliance counsel and distinguish potential civil billing issues from conduct that may fall outside the pilot. The next developments to watch are agency details on how disclosures are submitted and resolved, and whether officials address concerns about repayment burdens for small providers.

Key Questions

What is the self-disclosure pilot?

It is a six-month HHS and DOJ program allowing healthcare companies to voluntarily disclose certain civil False Claims Act violations and seek a coordinated resolution under the Act and some HHS administrative authorities.

Does the pilot cover criminal conduct under the Anti-Kickback Statute?

No. The source report describes the pilot as civil only. Cutia said referral-related conduct that may fall under the Anti-Kickback Statute is outside the program.

Why are home-based care providers paying attention to it?

Providers may uncover billing-related documentation problems in internal audits. Industry sources say the pilot could give organizations a more defined process for disclosing and resolving certain civil issues, though the cost and consequences of a disclosure remain important considerations.

When does the pilot end, and could it continue?

The six-month pilot is scheduled to end April 22, 2027. HCAOA has asked HHS and DOJ to consider an extension or permanent program, but no decision to extend it has been reported.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

Supernus Pharmaceuticals Surges In Global Coverage

Supernus Pharmaceuticals experiences a significant increase in international media mentions, indicating rising global interest in the company’s activities.

Food And Drug Administration

The FDA has introduced new regulations to improve food additive safety, aiming to better protect consumers and enhance transparency.

Social Security Added 14 Rare Diseases To Its Expedited List

Social Security has officially included 14 rare diseases to its expedited processing list, aiming to speed up disability benefit claims for affected individuals.

Centers For Disease surges in global coverage

CDC reports a surge in disease outbreaks worldwide, with 27 mentions in recent data, highlighting increased global health concerns.